Annual report pursuant to Section 13 and 15(d)

Discontinued Operations - Schedule of Fair Value of Acquired Assets and Liabilities Assumed (Details)

v3.19.3
Discontinued Operations - Schedule of Fair Value of Acquired Assets and Liabilities Assumed (Details) - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Sep. 27, 2017
Accounts payable and accrued expenses $ (193,966)  
Genomas Inc [Member]      
Cash     $ 7,990
Accounts receivable, net     6,503
Accounts payable and accrued expenses     (458,736)
Deferred revenue     (20,000)
Loans payable short-term     (142,514)
Note payable long-term     (134,118)
Total identifiable net liabilities     (740,875)
Goodwill     914,972
Total consideration     $ 174,097